Recombinant Human NR1H2 Protein，His

NR1H2, also known as Liver X Receptor Beta (LXRβ), is a member of the nuclear receptor superfamily that plays a pivotal role in lipid metabolism, cholesterol homeostasis, and inflammation. This receptor is activated by oxysterols, which are cholesterol derivatives that act as signaling molecules. Research into NR1H2 has gained momentum due to its significant implications in metabolic diseases, such as atherosclerosis, obesity, and diabetes, where dysregulated lipid metabolism is a major factor. The ability of NR1H2 to regulate genes involved in cholesterol efflux, fatty acid synthesis, and anti-inflammatory processes positions it as a potential therapeutic target for treating metabolic disorders. Moreover, studies have shown that NR1H2 can influence the immune response, linking it to conditions like autoimmune diseases and cancer. Recombining NR1H2 proteins for functional studies enables us to explore its binding interactions, transcriptional regulation capabilities, and downstream signaling pathways in detail. Understanding the mechanistic functions of NR1H2 through recombinant protein studies can advance our knowledge of its role in health and disease, potentially facilitating the development of novel pharmacological strategies aimed at modulating its activity for therapeutic benefit. Overall, the exploration of NR1H2 as a recombinantly produced protein represents a critical step in deciphering its biological significance and therapeutic potential in various metabolic and inflammatory conditions.